IMMUNIC, INC. — Director's Dealing 2024

Jul 12, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2024-07-12

Reporting Person: Tardio Jason (President and COO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-07-12	Stock Option	$1.25	A	500000	Acquired	2034-07-12	Common Stock (500000)	Direct

Footnotes

F1: The options disclosed on this Form 4 are time vested; 25 percent of the shares underlying the options awarded to the Reporting Person will vest on July 12, 2025, and 75 percent of them will vest in 36 equal monthly installments, subject to the Reporting Person remaining an employee of Immunic, Inc. in good standing through the relevant vesting date.